Related Experiment Video

Updated: Feb 2, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.3K

Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3

Weifeng Ding1, Weilin Pu2, Shuai Jiang2

  • 1State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China; Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China; University of Texas-McGovern Medical School, Houston, TX, USA.

Ebiomedicine
|November 25, 2018
PubMed
Abstract

Insights

This study shows that combining siRNAs targeting SPARC, CCR2, and SMAD3 genes effectively reduced inflammation and fibrosis in mice. This multi-target approach offers a promising new therapy for fibrotic disorders.

Area of Science:

  • Fibrosis research
  • RNA interference therapeutics
  • Inflammation and immunology

Background:

  • SPARC, CCR2, and SMAD3 genes are key players in inflammatory responses leading to fibrosis.
  • Scleroderma and other fibrotic conditions involve complex inflammatory pathways.

Purpose of the Study:

  • To assess the synergistic anti-fibrotic effects of combined siRNAs targeting SPARC, CCR2, and SMAD3.
  • To investigate the therapeutic potential of this multi-target siRNA approach in fibrotic disease models.

Main Methods:

  • Utilized a bleomycin-induced mouse model of fibrosis.
  • Assessed pathological changes using histological staining (H&E, Masson's trichrome).
  • Quantified gene and protein expression via RT-PCR, RNA sequencing, Western blot, and ELISA; measured collagen levels using Sircol assay.

Main Results:

  • Combined siRNAs demonstrated significant anti-inflammatory and anti-fibrotic effects in treated mice.
  • Fibroblast activation and inflammation were suppressed, with reduced inflammatory cells and cytokines.
  • Treatment normalized aberrant gene expression in multiple cell types and partially restored biological pathways.

Conclusions:

  • Combined siRNAs targeting SPARC, CCR2, and SMAD3 ameliorated inflammation and fibrosis in a mouse model.
  • The therapy likely works by modulating various cell types and restoring biological pathways.
  • This multi-target siRNA strategy presents a novel and potentially effective therapeutic option for fibrosis.
Keywords:
CCR2FibrosisInflammationMultiple targets-siRNAsPeptide nanoparticleSMAD3SPARCScleroderma

More Related Videos

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

11.1K
Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays08:06

Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays

Published on: November 10, 2016

8.0K

Related Concept Videos

Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
6.3K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.5K
Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Nursing Evaluation01:15

Nursing Evaluation

The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
4.4K
Self-Evaluation Maintenance Model01:29

Self-Evaluation Maintenance Model

The Self-Evaluation Maintenance (SEM) model offers a psychological framework to understand how individuals’ self-esteem is influenced by the achievements of others, particularly those with whom they share close personal bonds. The SEM model operates when personal rather than social identity guides individuals. Central to this model is the notion that individuals have an inherent desire to preserve a favorable self-image, which is continuously shaped by interpersonal comparisons and...
312
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
378